S&P 500   3,841.00 (+0.30%)
DOW   31,226.42 (-0.56%)
QQQ   315.72 (+0.92%)
AAPL   123.79 (+2.31%)
MSFT   232.94 (+1.72%)
FB   260.20 (+2.16%)
GOOGL   2,026.80 (+0.54%)
AMZN   3,082.00 (+0.81%)
TSLA   681.77 (-0.07%)
NVDA   545.07 (+2.40%)
BABA   241.08 (+0.37%)
CGC   32.65 (-1.69%)
GE   12.49 (-2.12%)
MU   90.52 (+2.72%)
NIO   46.21 (-1.28%)
AMD   84.67 (+2.73%)
T   28.42 (-0.73%)
F   11.65 (-0.94%)
ACB   10.79 (-0.28%)
DIS   186.10 (-2.56%)
BA   212.80 (-1.69%)
NFLX   548.27 (+0.29%)
BAC   34.92 (-2.81%)
S&P 500   3,841.00 (+0.30%)
DOW   31,226.42 (-0.56%)
QQQ   315.72 (+0.92%)
AAPL   123.79 (+2.31%)
MSFT   232.94 (+1.72%)
FB   260.20 (+2.16%)
GOOGL   2,026.80 (+0.54%)
AMZN   3,082.00 (+0.81%)
TSLA   681.77 (-0.07%)
NVDA   545.07 (+2.40%)
BABA   241.08 (+0.37%)
CGC   32.65 (-1.69%)
GE   12.49 (-2.12%)
MU   90.52 (+2.72%)
NIO   46.21 (-1.28%)
AMD   84.67 (+2.73%)
T   28.42 (-0.73%)
F   11.65 (-0.94%)
ACB   10.79 (-0.28%)
DIS   186.10 (-2.56%)
BA   212.80 (-1.69%)
NFLX   548.27 (+0.29%)
BAC   34.92 (-2.81%)
S&P 500   3,841.00 (+0.30%)
DOW   31,226.42 (-0.56%)
QQQ   315.72 (+0.92%)
AAPL   123.79 (+2.31%)
MSFT   232.94 (+1.72%)
FB   260.20 (+2.16%)
GOOGL   2,026.80 (+0.54%)
AMZN   3,082.00 (+0.81%)
TSLA   681.77 (-0.07%)
NVDA   545.07 (+2.40%)
BABA   241.08 (+0.37%)
CGC   32.65 (-1.69%)
GE   12.49 (-2.12%)
MU   90.52 (+2.72%)
NIO   46.21 (-1.28%)
AMD   84.67 (+2.73%)
T   28.42 (-0.73%)
F   11.65 (-0.94%)
ACB   10.79 (-0.28%)
DIS   186.10 (-2.56%)
BA   212.80 (-1.69%)
NFLX   548.27 (+0.29%)
BAC   34.92 (-2.81%)
S&P 500   3,841.00 (+0.30%)
DOW   31,226.42 (-0.56%)
QQQ   315.72 (+0.92%)
AAPL   123.79 (+2.31%)
MSFT   232.94 (+1.72%)
FB   260.20 (+2.16%)
GOOGL   2,026.80 (+0.54%)
AMZN   3,082.00 (+0.81%)
TSLA   681.77 (-0.07%)
NVDA   545.07 (+2.40%)
BABA   241.08 (+0.37%)
CGC   32.65 (-1.69%)
GE   12.49 (-2.12%)
MU   90.52 (+2.72%)
NIO   46.21 (-1.28%)
AMD   84.67 (+2.73%)
T   28.42 (-0.73%)
F   11.65 (-0.94%)
ACB   10.79 (-0.28%)
DIS   186.10 (-2.56%)
BA   212.80 (-1.69%)
NFLX   548.27 (+0.29%)
BAC   34.92 (-2.81%)
Log in
NASDAQ:DOX

Amdocs Competitors

$76.04
-0.63 (-0.82 %)
(As of 02/26/2021 11:03 AM ET)
Add
Compare
Today's Range
$75.27
Now: $76.04
$76.61
50-Day Range
$69.63
MA: $73.42
$78.26
52-Week Range
$44.05
Now: $76.04
$78.50
Volume7,242 shs
Average Volume836,224 shs
Market Capitalization$9.97 billion
P/E Ratio20.55
Dividend Yield1.69%
Beta0.76

Competitors

Amdocs (NASDAQ:DOX) Vs. ACN, IBM, CTSH, EPAM, IT, and LDOS

Should you be buying DOX stock or one of its competitors? Companies in the sub-industry of "it consulting & other services" are considered alternatives and competitors to Amdocs, including Accenture (ACN), International Business Machines (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Gartner (IT), and Leidos (LDOS).

Amdocs (NASDAQ:DOX) and Accenture (NYSE:ACN) are both large-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Amdocs and Accenture's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Amdocs11.94%15.57%9.40%
Accenture11.74%29.32%13.92%

Earnings and Valuation

This table compares Amdocs and Accenture's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amdocs$4.17 billion2.39$497.84 million$4.1918.15
Accenture$44.33 billion3.77$5.11 billion$7.4633.96

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.0% of Amdocs shares are held by institutional investors. Comparatively, 71.0% of Accenture shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 0.1% of Accenture shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Amdocs and Accenture, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Amdocs00303.00
Accenture091302.59

Amdocs currently has a consensus price target of $82.00, indicating a potential upside of 8.18%. Accenture has a consensus price target of $253.0417, indicating a potential upside of 0.33%. Given Amdocs' stronger consensus rating and higher possible upside, equities research analysts plainly believe Amdocs is more favorable than Accenture.

Dividends

Amdocs pays an annual dividend of $1.31 per share and has a dividend yield of 1.7%. Accenture pays an annual dividend of $3.52 per share and has a dividend yield of 1.4%. Amdocs pays out 31.3% of its earnings in the form of a dividend. Accenture pays out 47.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 7 consecutive years and Accenture has increased its dividend for 1 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk and Volatility

Amdocs has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Accenture has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Summary

Accenture beats Amdocs on 9 of the 17 factors compared between the two stocks.

Amdocs (NASDAQ:DOX) and International Business Machines (NYSE:IBM) are both large-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Amdocs and International Business Machines' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Amdocs11.94%15.57%9.40%
International Business Machines10.53%48.69%6.59%

Earnings and Valuation

This table compares Amdocs and International Business Machines' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amdocs$4.17 billion2.39$497.84 million$4.1918.15
International Business Machines$77.15 billion1.39$9.43 billion$12.819.38

International Business Machines has higher revenue and earnings than Amdocs. International Business Machines is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.0% of Amdocs shares are held by institutional investors. Comparatively, 55.7% of International Business Machines shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 0.2% of International Business Machines shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Amdocs and International Business Machines, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Amdocs00303.00
International Business Machines08502.38

Amdocs currently has a consensus price target of $82.00, indicating a potential upside of 8.18%. International Business Machines has a consensus price target of $139.8462, indicating a potential upside of 16.52%. Given International Business Machines' higher possible upside, analysts plainly believe International Business Machines is more favorable than Amdocs.

Dividends

Amdocs pays an annual dividend of $1.31 per share and has a dividend yield of 1.7%. International Business Machines pays an annual dividend of $6.52 per share and has a dividend yield of 5.4%. Amdocs pays out 31.3% of its earnings in the form of a dividend. International Business Machines pays out 50.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 7 consecutive years and International Business Machines has increased its dividend for 21 consecutive years. International Business Machines is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk and Volatility

Amdocs has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, International Business Machines has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.

Summary

International Business Machines beats Amdocs on 9 of the 17 factors compared between the two stocks.

Amdocs (NASDAQ:DOX) and Cognizant Technology Solutions (NASDAQ:CTSH) are both large-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Amdocs and Cognizant Technology Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Amdocs11.94%15.57%9.40%
Cognizant Technology Solutions8.78%19.04%11.79%

Earnings and Valuation

This table compares Amdocs and Cognizant Technology Solutions' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amdocs$4.17 billion2.39$497.84 million$4.1918.15
Cognizant Technology Solutions$16.78 billion2.33$1.84 billion$3.9918.43

Cognizant Technology Solutions has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Cognizant Technology Solutions, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.0% of Amdocs shares are held by institutional investors. Comparatively, 87.7% of Cognizant Technology Solutions shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 0.3% of Cognizant Technology Solutions shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Amdocs and Cognizant Technology Solutions, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Amdocs00303.00
Cognizant Technology Solutions381302.42

Amdocs currently has a consensus price target of $82.00, indicating a potential upside of 8.18%. Cognizant Technology Solutions has a consensus price target of $77.9048, indicating a potential upside of 6.53%. Given Amdocs' stronger consensus rating and higher possible upside, equities research analysts plainly believe Amdocs is more favorable than Cognizant Technology Solutions.

Dividends

Amdocs pays an annual dividend of $1.31 per share and has a dividend yield of 1.7%. Cognizant Technology Solutions pays an annual dividend of $0.96 per share and has a dividend yield of 1.3%. Amdocs pays out 31.3% of its earnings in the form of a dividend. Cognizant Technology Solutions pays out 24.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 7 consecutive years and Cognizant Technology Solutions has increased its dividend for 1 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk and Volatility

Amdocs has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Cognizant Technology Solutions has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

Summary

Amdocs beats Cognizant Technology Solutions on 9 of the 17 factors compared between the two stocks.

Amdocs (NASDAQ:DOX) and EPAM Systems (NYSE:EPAM) are both large-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

Analyst Recommendations

This is a summary of recent ratings and price targets for Amdocs and EPAM Systems, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Amdocs00303.00
EPAM Systems021102.85

Amdocs currently has a consensus price target of $82.00, indicating a potential upside of 8.18%. EPAM Systems has a consensus price target of $363.3077, indicating a potential upside of 0.36%. Given Amdocs' stronger consensus rating and higher possible upside, equities research analysts plainly believe Amdocs is more favorable than EPAM Systems.

Profitability

This table compares Amdocs and EPAM Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Amdocs11.94%15.57%9.40%
EPAM Systems12.31%18.29%13.20%

Valuation and Earnings

This table compares Amdocs and EPAM Systems' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amdocs$4.17 billion2.39$497.84 million$4.1918.15
EPAM Systems$2.29 billion8.99$261.06 million$4.9175.04

Amdocs has higher revenue and earnings than EPAM Systems. Amdocs is trading at a lower price-to-earnings ratio than EPAM Systems, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Amdocs has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Comparatively, EPAM Systems has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500.

Institutional and Insider Ownership

89.0% of Amdocs shares are held by institutional investors. Comparatively, 92.0% of EPAM Systems shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 4.8% of EPAM Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

EPAM Systems beats Amdocs on 9 of the 14 factors compared between the two stocks.

Gartner (NYSE:IT) and Amdocs (NASDAQ:DOX) are both large-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Gartner and Amdocs, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Gartner03302.50
Amdocs00303.00

Gartner currently has a consensus price target of $168.1667, indicating a potential downside of 6.25%. Amdocs has a consensus price target of $82.00, indicating a potential upside of 8.18%. Given Amdocs' stronger consensus rating and higher possible upside, analysts clearly believe Amdocs is more favorable than Gartner.

Profitability

This table compares Gartner and Amdocs' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Gartner5.13%41.76%5.84%
Amdocs11.94%15.57%9.40%

Earnings & Valuation

This table compares Gartner and Amdocs' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gartner$4.25 billion3.80$233.29 million$3.9046.34
Amdocs$4.17 billion2.39$497.84 million$4.1918.15

Amdocs has lower revenue, but higher earnings than Gartner. Amdocs is trading at a lower price-to-earnings ratio than Gartner, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Gartner has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Amdocs has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.

Institutional & Insider Ownership

92.3% of Gartner shares are owned by institutional investors. Comparatively, 89.0% of Amdocs shares are owned by institutional investors. 4.0% of Gartner shares are owned by company insiders. Comparatively, 15.4% of Amdocs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Amdocs beats Gartner on 7 of the 13 factors compared between the two stocks.

Leidos (NYSE:LDOS) and Amdocs (NASDAQ:DOX) are both large-cap aerospace companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Leidos and Amdocs, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Leidos011202.92
Amdocs00303.00

Leidos currently has a consensus price target of $116.3636, indicating a potential upside of 28.92%. Amdocs has a consensus price target of $82.00, indicating a potential upside of 8.18%. Given Leidos' higher possible upside, research analysts clearly believe Leidos is more favorable than Amdocs.

Profitability

This table compares Leidos and Amdocs' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Leidos5.10%23.45%7.35%
Amdocs11.94%15.57%9.40%

Dividends

Leidos pays an annual dividend of $1.36 per share and has a dividend yield of 1.5%. Amdocs pays an annual dividend of $1.31 per share and has a dividend yield of 1.7%. Leidos pays out 26.3% of its earnings in the form of a dividend. Amdocs pays out 31.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Leidos has raised its dividend for 1 consecutive years and Amdocs has raised its dividend for 7 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Valuation & Earnings

This table compares Leidos and Amdocs' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Leidos$11.09 billion1.16$667 million$5.1717.48
Amdocs$4.17 billion2.39$497.84 million$4.1918.15

Leidos has higher revenue and earnings than Amdocs. Leidos is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Leidos has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, Amdocs has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.

Institutional & Insider Ownership

74.2% of Leidos shares are owned by institutional investors. Comparatively, 89.0% of Amdocs shares are owned by institutional investors. 1.5% of Leidos shares are owned by insiders. Comparatively, 15.4% of Amdocs shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Leidos beats Amdocs on 9 of the 17 factors compared between the two stocks.


Amdocs Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Accenture logo
ACN
Accenture
2.2$253.32-0.2%$167.21 billion$44.33 billion31.20
International Business Machines logo
IBM
International Business Machines
2.7$120.13-1.9%$109.13 billion$77.15 billion13.60
Cognizant Technology Solutions logo
CTSH
Cognizant Technology Solutions
2.3$73.54-0.2%$38.94 billion$16.78 billion27.24
EPAM Systems logo
EPAM
EPAM Systems
2.0$368.47-1.2%$20.39 billion$2.29 billion67.86Analyst Report
Gartner logo
IT
Gartner
1.0$180.74-1.6%$15.88 billion$4.25 billion75.94
Leidos logo
LDOS
Leidos
2.3$90.35-1.4%$12.69 billion$11.09 billion21.26Earnings Announcement
Dividend Announcement
Analyst Report
Analyst Revision
Booz Allen Hamilton logo
BAH
Booz Allen Hamilton
2.1$78.98-1.1%$10.76 billion$7.46 billion21.52Analyst Report
Unusual Options Activity
News Coverage
CACI International logo
CACI
CACI International
1.8$224.54-0.3%$5.68 billion$5.72 billion16.49Analyst Report
Teradata logo
TDC
Teradata
1.1$39.89-2.9%$4.48 billion$1.90 billion44.82Analyst Report
ManTech International logo
MANT
ManTech International
2.2$79.87-0.3%$3.21 billion$2.22 billion25.12Analyst Report
Unisys logo
UIS
Unisys
1.0$24.16-3.6%$1.58 billion$2.95 billion1.66Earnings Announcement
Virtusa logo
VRTU
Virtusa
1.6$51.33-0.0%$1.56 billion$1.31 billion41.73
Forrester Research logo
FORR
Forrester Research
1.4$45.37-0.2%$862.48 million$461.70 million68.74News Coverage
The Hackett Group logo
HCKT
The Hackett Group
2.2$15.99-0.4%$480.89 million$282.47 million79.95Earnings Announcement
Dividend Increase
Analyst Report
Analyst Revision
News Coverage
ServiceSource International logo
SREV
ServiceSource International
1.6$1.62-0.0%$156.49 million$216.13 million-7.71
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.